Correlation Between Milestone Pharmaceuticals and Alkermes Plc
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Alkermes Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Alkermes Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Alkermes Plc, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Alkermes Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Alkermes Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Alkermes Plc.
Diversification Opportunities for Milestone Pharmaceuticals and Alkermes Plc
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Milestone and Alkermes is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Alkermes Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alkermes Plc and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Alkermes Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alkermes Plc has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Alkermes Plc go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Alkermes Plc
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to under-perform the Alkermes Plc. In addition to that, Milestone Pharmaceuticals is 1.99 times more volatile than Alkermes Plc. It trades about -0.02 of its total potential returns per unit of risk. Alkermes Plc is currently generating about 0.0 per unit of volatility. If you would invest 3,113 in Alkermes Plc on September 1, 2024 and sell it today you would lose (211.00) from holding Alkermes Plc or give up 6.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Alkermes Plc
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Alkermes Plc |
Milestone Pharmaceuticals and Alkermes Plc Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Alkermes Plc
The main advantage of trading using opposite Milestone Pharmaceuticals and Alkermes Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Alkermes Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alkermes Plc will offset losses from the drop in Alkermes Plc's long position.The idea behind Milestone Pharmaceuticals and Alkermes Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Alkermes Plc vs. Cue Biopharma | Alkermes Plc vs. Tff Pharmaceuticals | Alkermes Plc vs. Lantern Pharma | Alkermes Plc vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |